The search for lupus biomarkers to diagnose, monitor, stratify, and predict individual
response to therapy is currently more intense than ever before. This effort is essential for …

Abstract Objective The Systemic Lupus International Collaborating Clinics (SLICC) group
revised and validated the American College of Rheumatology (ACR) systemic lupus …

The authors ascertained cardiovascular events (myocardial infarction and angina pectoris)
in 498 women with systemic lupus erythematosus seen at the University of Pittsburgh …

Objective To examine mortality rates in the largest systemic lupus erythematosus (SLE)
cohort ever assembled. Methods Our sample was a multisite international SLE cohort (23 …

Our focus on the causes of vascular disease in systemic lupus erythematosus must now
include nontraditional risk factors such as immune and inflammatory mediators. With the …

The urgent need for lupus biomarkers was demonstrated in September 2011 during a
Workshop sponsored by the Food and Drug Administration: Potential Biomarkers Predictive …

Background Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease in
which the risk of disease is influenced by complex genetic and environmental contributions …

Genome-wide association studies have recently identified at least 15 susceptibility loci for
systemic lupus erythematosus (SLE). To confirm additional risk loci, we selected SNPs from …

Objective To determine the prevalence of carotid atherosclerosis and associated risk factors
in women with systemic lupus erythematosus (SLE). Methods Carotid plaque and intima …

Background: There is concern that exogenous female hormones may worsen disease
activity in women with systemic lupus erythematosus (SLE). Objective: To evaluate the effect …